EU drug and device regulators have joined hands to issue guidance on the factors that companies should consider when undertaking clinical trials using diagnostic assays, including combined trials for the development of companion diagnostics (CDx).
Regulations on clinical trials and IVDs in the EU have both undergone significant change recently and the guideline, issued in...